ICB&DD Symposium October 2, 2025
At the conference dinner: Symposium Chair, Ivet Bahar, with the speakers (Drs Dokholyan and Filizola) and ICB & DD Director Iwao Ojima
Oct 2, 2o25
The ICB&DD 19th Annual Symposium, "Drug Discovery & AI: Advances and New Directions" was held at the Charles Wang Center on Thursday, October 2, 2025 (9:00AM–5:00PM; Reception 5:00–6:00PM). The ICB&DD Annual Symposium is thematically focused on cutting-edge advances in chemical biology, structural and computational biology, cancer and infectious diseases, and drug discovery. This year’s symposium was organized by the Laufer Center Director, Ivet Bahar (Chair) and Laufer Center & UT Austin Faculty Dima Kozakov (co-Chair).
The Symposium invites renowned scholars in the field as well as highly recognized researchers on campus to present their exciting accomplishments and stimulate the exchange of innovative ideas among speakers, faculty, staff, and students on campus as well as researchers at the Brookhaven National Laboratory, academia and industries in the greater NY metropolitan area.
The Plenary Lecturers this year were:
Dr. Nikolay Dokholyan, University of Virginia
Dr. Maria Wendt, Sanofi, Cambridge, MA
Dr. Marta Filizola, Icahn School of Medicine
Dr. David Koes, U of Pittsburgh School of Medicine
Dr. Chris Sander, Harvard Medical School & Broad Institute
Dr. Patrick Walters, OpenADMET
Dr. Dima Kozakov, UT Austin
Dr. David LeBard (OpenEye/Cadence)
Please see the link for the registration and poster sessions in https://www.stonybrook.edu/commcms/icbdd/
https://www.stonybrook.edu/commcms/icbdd/symposium.php
